Blood DNA test better selects patients for prostate cancer radiopharmaceutical therapy
A simple blood test may soon help clinicians manage metastatic castration-resistant prostate cancer (mCRPC) more precisely, according to a study...
IRP1/ARID3A complex identified as a new epigenetic driver of pancreatic cancer chemoresistance
Pancreatic cancer remains among the deadliest malignancies, in part because tumors often withstand chemotherapy and later acquire resistance. In recent...
Biological Markers of Cancer-Related Fatigue Found in Older Male Survivors
Cancer-related fatigue can linger long after treatment ends, but the biological mechanisms behind that weariness remain difficult to pinpoint—especially in...
ZBP1 Links Genomic Stress to Tumor Immunity, New Study Finds
A new open-access Review in Ferroptosis and Oxidative Stress spotlights Z-nucleic acid-binding protein 1 (ZBP1), framing it as an emerging...
New drug candidate offers hope for patients with NRAS-driven melanoma
A Huntsman Cancer Institute team at the University of Utah reports that daraxonrasib, a targeted RAS inhibitor, could offer a...
Association for Molecular Pathology Names 2026 Award Winners
ROCKVILLE, Md.—The Association for Molecular Pathology (AMP) has announced the 2026 recipients of its Award for Excellence in Molecular Diagnostics,...
Safe vaccine triggers durable immune responses to prevent pancreatic cancer in high-risk people
A first-in-human study reported that an off-the-shelf vaccine aimed at common mutant KRAS variants can be both safe and immunologically...
Scientists engineer next-generation cancer treatments by disabling tumor DNA repair
DETROIT — Traditional cancer therapies such as radiation and chemotherapy attack tumor cells by damaging their DNA, but many cancers...
Early inflammation signal fuels oral cancer, suggests immunoprevention strategy
Researchers at The University of Texas MD Anderson Cancer Center report an immune pathway that may help oral precancerous lesions...
LIG1 Loss Reveals Targetable Weakness Against Chemotherapy-Resistant Triple-Negative Breast Cancer
In triple-negative breast cancer (TNBC) that carries TP53 mutations, loss of one copy of the DNA ligase I gene (LIG1)...
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!